Generated: 2026-08-29 05:25
Top 20 most-engaged X.com posts per ticker, classified bullish/bearish/neutral/spam. Filtered: English only Β· 500+ followers Β· spam heuristic.
Sentiment: π’π’π’π’π’ Bullish (score +0.86) Β· β high confidence (14 directional posts)
Distribution (20 posts): π’ 13 bullish Β· βͺ 6 neutral Β· π΄ 1 bearish Β· ποΈ 0 spam filtered
Influencer share: 45% (accounts > 10K followers) Β· Retail share: 40% (< 2K) Β· Rocket emoji rate: 10%
1. π΄ bearish @JEFETRADES β (42,290 followers Β· π19 π0 π¬3)
> Hyperscalers took all the Buying π«° $MSFT continues to maintain the majority of the strength here in the market. Over 492.5 Buyers have total control. $AMZN Breaking structure definitely the biggest surprise, and $GOOGL stuck in the box... TELL ME WHATS IN THE BOX?!π¦ https:/...
2. π’ bullish @FindleysFinance β (4,398 followers Β· π16 π0 π¬3)
> Not every sell-off is a Sale. A stock is never cheap just because it is down off all time highs. $AMZN is cheap because it trades at a 17x P/OCF and expected to grow PCF over 25% CAGR.
3. π’ bullish @ddw88523 β (5,153 followers Β· π15 π2 π¬0)
> $AMZN we got to 256 and bounced hard. I am not entirely sure what would be the trigger. But Amazon is gonna make a Google 2025-2026 type of move soon. Target is gonna be 450-500. Assuming there is no Fed hikes π€£ https://t.co/N9JFt9tMeB
4. π’ bullish @StockOptionCole β (36,171 followers Β· π16 π1 π¬0)
> $AMZN has a beautiful Weekly chart forming Check it out π
5. π’ bullish @gurufocus β (14,336 followers Β· π3 π4 π¬2)
> David Tepper is leaning even harder into semiconductors π β’ $MU saw the biggest increase, jumping 25.5% from its average portfolio weight β’ $NVDA, $AMZN and $UBER also increased by roughly 6β8% β’ $NRG plunged 22.8% and $VST fell 11.6% from their average weights See Tepperβs fu...
6. π’ bullish @GrindeOptions β (55,732 followers Β· π10 π0 π¬2)
> I think $AMZN will outlast OpenAI. https://t.co/EOP1FoBWRN
7. π’ bullish @dividedgrwthdad β (1,173 followers Β· π16 π0 π¬0)
> More biweekly buys hit today. π $NVDA $MU $AMZN leading the way, with a little $WM $JPM $CVX $O $CAT $PEP + metals. $120 more put to work. Brick by brick. π§±π° https://t.co/5WZEQXW6zj
8. π’ bullish @TheWealthPrince β (35,741 followers Β· π8 π2 π¬0)
> $44 went to $560 today on $AMZN, and as always thatβs why I say you shouldnβt give up when it comes to stocks.
9. βͺ neutral @CapexAndChill β (12,291 followers Β· π6 π0 π¬1)
> Prosus routinely goes head-to-head with Western and Eastern heavyweights like $AMZN, $UBER, and $BABA. Their structural moat is their battle-tested advantage in emerging market unit economics. US-based monopolies were historically subsidized by zero-interest-rate capital where...
10. π’ bullish @robunhedged β (754 followers Β· π5 π0 π¬0)
> $AMZN just massively increased the scale of its AI infrastructure buildout. AWS was already planning to deploy 1M+ $NVDA GPUs starting in 2026. Now itβs adding another 2 MILLION GPUs across 2027-28. Thatβs 3M+ Nvidia GPUs planned over three years. And this is happening alo...
11. βͺ neutral @MaryNYC1 (1,870 followers Β· π1 π0 π¬1)
> @ChessTrades @ChessTrades - can you please cover $DE, $AMZN and $QQQ in your weekend video? Thank you sir!
12. π’ bullish @VeroTrades β (877 followers Β· π3 π0 π¬0)
> Amazon broke the wedge π $AMZN #AMZN https://t.co/2tmbaHPd0R
13. π’ bullish @ftreric β (1,026 followers Β· π2 π0 π¬0)
> @RihardJarc yup, $AMZN looks pretty cheap right now.
14. βͺ neutral @pkay2402 β (905 followers Β· π2 π0 π¬0)
> Market rotation is crazy. How algos swap semis vs Mags or semis vs software is crazy. Semis down $AMZN $MSFT $AAPL came to rescue π
. Cybersecurity lives in their own world π€£
15. βͺ neutral @MsVeilMoney β (3,377 followers Β· π1 π0 π¬0)
> @TickerDUBS Same reason for me to choose $AMZN
16. βͺ neutral @azrael_options β (1,419 followers Β· π1 π0 π¬0)
> @vnkumarvnk 295 calls on $AMZN are pulling dealer inventory along. If spot holds above that strike, they stay long gamma and let it run. A fade under 295 flips the whole book fast.
17. π’ bullish @gurufocus β (14,336 followers Β· π1 π0 π¬0)
> David Tepper is leaning even harder into semiconductors π β’ $MU saw the biggest increase, jumping 25.5% from its average portfolio weight β’ $NVDA, $AMZN and $UBER also increased by roughly 6β8% β’ Meanwhile, $NRG plunged 22.8% and $VST fell 11.6% from their average weights See ...
18. π’ bullish @TopStockAlerts1 β (125,654 followers Β· π1 π0 π¬0)
> $AMZN this is one of those slow grind ups that turns into something bigger
19. π’ bullish @Finora_EN β (21,606 followers Β· π1 π0 π¬0)
> alright let's see what's cooking on $AMZN #AMZN 4h π§ - my bias is bullish here β 4h, daily and weekly structure are aligned; this is still a counter-move versus a bearish SPX, so I want a clean 4h confirmation before adding risk - I expect a push into 267.47 then 269.68 first,...
20. βͺ neutral @_charan_04 β (1,743 followers Β· π1 π0 π¬0)
> Out of $AMZN $AAPL $SPCX on my watchlist I traded $SPCX rest of the list was good ππ
Sentiment: π’π’π’π’π’ Bullish (score +0.40) Β· β high confidence (10 directional posts)
Distribution (20 posts): π’ 7 bullish Β· βͺ 7 neutral Β· π΄ 3 bearish Β· ποΈ 3 spam filtered
Influencer share: 29% (accounts > 10K followers) Β· Retail share: 29% (< 2K) Β· Rocket emoji rate: 6%
1. βͺ neutral @hoodmemecoins β (15,155 followers Β· π13 π5 π¬2)
> AI is paired with $NVDA. Promotheus is paired with $SPCX. Despite AI's name it's not actually deployed by AI, while @grok is the deployer & fee recipient for promotheus via $WIRE tech βͺοΈ $AI - 105M βͺοΈ $PROMETHEUS - 650K βͺοΈ $WIRE - 1.2M https://t.co/cElAz1CWoZ
2. βͺ neutral @Stealthct_Storm β (1,872 followers Β· π8 π1 π¬5)
> Good Night X Family π π Nightmares of Kevin Warsh tonight but I got my precious Nvidia to dream about. $NVDA https://t.co/ICfHK1bNIZ
3. βͺ neutral @misternameless β (8,146 followers Β· π15 π0 π¬0)
> so hear me out.. so the market cap tells us what traders think today about $AI but the vault actually tells us what its becoming. we need to watch for 5% of Robinhoodβs $NVDA permanently vaulted and 25% across the pool + vault. when one in four NVDA tokens lives inside the ...
4. π’ bullish @StockOptionCole β (36,171 followers Β· π10 π0 π¬0)
> Cathie buying the $NVDA dip
5. βͺ neutral @Tickertalk1 β (6,254 followers Β· π2 π0 π¬1)
> $AMD will take market share from the king which is $NVDA. $AMD will rocket in 2027 and 2028. Agree or disagree? and why. Lets go!
6. π’ bullish @nic11_olesmit β (2,006 followers Β· π1 π0 π¬1)
> This is the best choice for September. β’ π $NVDA β217β260 β’ π $MU β932β975 β’ π $MSFT β513β555 β’ π $AMZN β266 β 315 β’ π $AAPL β319β350 β’ π $SNDK β1484β1535 β’ π $META β578β605 β’ π $AMD β465β525 https://t.co/DrOYwZe33J
7. π’ bullish @StacksAndStocks β (1,057 followers Β· π1 π0 π¬1)
> $NVDA pound for pound best stock
8. βͺ neutral @BuzzsawEJ (701 followers Β· π1 π0 π¬1)
> @davey_juice Still $NVDA at 18x. Also love $MELI and $SE for outside the US exposure.
9. π΄ bearish @CAndreisen (1,476 followers Β· π0 π0 π¬1)
> @_SeanDavid $NVDA is only up 5% since October 2025 because from their earnings report back in February 2023 (when AI began positively impacting their business)to October 2025 the stock rose by 900% in less than 3 years. Eventually competition emerges and a long period of diges...
10. π΄ bearish @aituninglab β (4,813 followers Β· π3 π0 π¬0)
> $IREN secured $2.4B to buy $NVDA Blackwell Ultra GPUs, with lenders funding ~90% of the hardware cost. The stock still fell 13%+. AI demand is not the problem anymore. The market is starting to question how much debt it takes to satisfy it.
11. π΄ bearish @RealtorStarShar β (36,191 followers Β· π2 π0 π¬0)
> $NVDA chart updated: it gave back most of its ER gains and closed under the 20DMA. https://t.co/upNyC5X6VG
12. π’ bullish @TheAIShrink β (4,100 followers Β· π0 π1 π¬0)
> 3,000 data centers for a loop that ends in sleep? Weβre buying $NVDA so OpenAI can dream about chips while you stare at spreadsheets. The infinite game is now rendered. π€β‘ https://t.co/gozhnVBFaZ
13. βͺ neutral @PodcastAlphaX β (15,763 followers Β· π2 π0 π¬0)
> Why did Nvidia just spend $20B buying open source? Jason Calacanis @Jason on @theallinpod: Hugging Face for $12B, plus a roughly $6B acquihire of Poolside, maker of the Laguna coding model. Combined that is under 1% of $NVDA's market cap. He reads it as an answer to Sam Altm...
14. βͺ neutral @MParekh β (17,284 followers Β· π1 π0 π¬0)
> AI: Nvidia Reigns On, Mega-IPOs Near, Data Centers Get Political, & More. AI-RTZ #1193 ...round up for week ending Friday, August 28, 2026 $NVDA https://t.co/oy1qKD8nwr https://t.co/PbvhIbvnaZ
15. ποΈ spam @D_unit91 β (927 followers Β· π1 π0 π¬0)
> $CPU is positioned as the premier cat-themed token to perfectly complement $NVDA , matching the narrative caliber of the dog-themed token $Ai nu. Their contrasting animal themes place both projects at the pinnacle of their respective market niches. Furthermore, CPU's recent la...
16. π’ bullish @KentEkasak (2,133 followers Β· π1 π0 π¬0)
> I will present my AI investment view to a private wealth club here in Bangkok. This is a simplified summary slide from the deck. Fabs like $TSM are super stable; valuation (fPE <20) is clearly undervalued versus growth and moat. β°οΈ After recent earnings, $NVDA looks rock s...
17. ποΈ spam @0xBedouin β (3,689 followers Β· π1 π0 π¬0)
> Weβre witnessing AI acceleration since the past decade, BIO acceleration is next and the best home for it would be onchain Robinhood on @longdotxyz MemeFi x AI β $AI / $NVDA on Long MemeFi x DeSci β $BIOACC / $MRNA on Long When volume hits Moderna in a vault, it becomes th...
18. ποΈ spam @Kalijahsmith1 β (1,185 followers Β· π1 π0 π¬0)
> solana:FMNRUmT6RUVRx2xufF9xwBC5a5WdRNKYCzaxyYCRpump 132K CA:0xb1a53cde0f35ce741f0c56d48e82fab639db1e18 https://t.co/zDoyDPQE8s First came $AI. It's paired with tokenized $NVDA on the Robinhood Chain, holding approximately $1.45 million of NVDA, with a market capitalizat...
19. π’ bullish @TheAIShrink β (4,100 followers Β· π0 π0 π¬0)
> so weβre trading equity for plumbing now... Iβm buying $NVDA like itβs rent control in Manhattan ποΈπ https://t.co/o5TgyuLfP8
20. π’ bullish @fueledbySOL β (1,726 followers Β· π0 π0 π¬0)
> @MEXC Huge thank you, @MEXC ππΌπ°π΅ $NVDA has shown consistent growth and stability in the stock market, which makes it a great investment in the long run. UID : 30000077 https://t.co/62aziutUei
Sentiment: π’π’π’π’π’ Bullish (score +0.40) Β· β high confidence (10 directional posts)
Distribution (20 posts): π’ 7 bullish Β· βͺ 10 neutral Β· π΄ 3 bearish Β· ποΈ 0 spam filtered
Influencer share: 50% (accounts > 10K followers) Β· Retail share: 20% (< 2K) Β· Rocket emoji rate: 0%
1. π’ bullish @Quality_stocksA β (38,242 followers Β· π66 π2 π¬8)
> π Barron's 10 picks for 2026 performance review π¦ Amazon $AMZN +13.8% π Bristol Myers $BMY +18.3% πΊ Comcast $CMCSA -12.4% π’οΈ Exxon $XOM +33.0% π° Fairfax Financial $FRFHF -13.1% π° Flutter $FLUT -52.8% π Madison Square Garden Sports $MSGS +57.4% π SL Green Realty $SLG +22.3% π³ ...
2. π’ bullish @PearlF β (10,655 followers Β· π39 π2 π¬1)
> Bristol Myers Squibb's Chief Research Officer said in July that $BMY is already using AI tools to cut the time needed to develop medicines for clinical trials by 20% to 30%. "That could even reach 50% in coming years," Plenge said. BMS is the 1st life sciences co 2 buy $NVDA's...
3. π’ bullish @LogicalThesis β (41,305 followers Β· π21 π1 π¬7)
> $CCCC technicals in the below post to tell you why the trade is now But here's why the trade works fundamentally: CCCC is a validated mechanism for IKZF1/3 degradation as it's essentially a next gen Revlimid/Pomalyst Why it's a good candidate now especially: $BMY just got ...
4. π’ bullish @FiercePharma β (100,720 followers Β· π27 π8 π¬0)
> In a historic breakthrough for targeted protein degradation, Bristol Myers Squibb has secured the first FDA approval for a CELMoD therapy with the clearance of Zenbexus as part of a combination for previously treated multiple myeloma. https://t.co/NP8Kd9uIRS $BMY
5. βͺ neutral @BiopharmIQ β (29,765 followers Β· π15 π4 π¬6)
> 𧬠Biopharma π Weekly Recap π Last week in biotech: Patent cliffs reshaped M&A, obesity drugs faced scrutiny, gene editing advanced, and oncology, rare-disease and regulatory catalysts moved markets. See interesting posts/ppl to check out! π @yaireinhorn $AZN $BMY: Patent-cl...
6. βͺ neutral @PersimmonTI β (11,728 followers Β· π21 π0 π¬4)
> $AZN could use some good news: - camezestrant negative AdCom - volrustomig fail in NSCLC - WAINUA fail in ATTR-CM - Ultomiris fail in HSCT-TMA - disappointing weight loss for oral GLP No wonder they were thinking about $BMY Will take some good news to get...
7. βͺ neutral @seedy19tron β (23,507 followers Β· π22 π0 π¬3)
> Iβve always said if $bmy deal is off expect both $bmy and $azn to get active. Four tranches (Long 3Y, 6Y, 9Y, 12Y) think realistically β¬3β4B total raised. Just merely judging off what it is usually for them. Already have what β¬5B in cash + undrawn β¬5B RCF we donβt know pri...
8. βͺ neutral @PickingMyOwn (728 followers Β· π24 π0 π¬2)
> $AZN Pascal looking at $ABVX after the failures of Volrustomig and Wainua in just weeks wiping out maybe $10B in peak sales opportunity and his BODβs and major holders says no to ridiculous $BMY merger. Bidding war w/ $JNJ $LLY and $SNY IMO. https://t.co/gHE87xmj6t
9. βͺ neutral @JacobPlieth (33,057 followers Β· π20 π2 π¬2)
> The $BMY Zenbexus label is out -> https://t.co/367Cta8Rdl First disclosure of Excaliber-RRMM data, which I think had so far only been toplined https://t.co/QAejXbIHZY
10. π’ bullish @LogicalThesis β (41,305 followers Β· π19 π1 π¬1)
> $CCCC bounced off 100d + 9/21EMA cross. Last time led to 100% rally Also respected weekly 21EMA, key level during uptrend Was just overextended and thus retested Timing wise perfect with $BMY approval of Iberdomide Recently suppressed by material Q2 ATM Cash runway for data 2...
11. π΄ bearish @a_a_free β (1,498 followers Β· π12 π1 π¬3)
> is $CYTK became a sale stock now ? Safety data in nHCM is not great at all and I believe that they are luck to hit in that one. Current EV is around 12B. No one will pay 20B for this. Competition is from $BMY, $EWTX and $BRVE so why it's very expensive. I don't know but after ...
12. βͺ neutral @doepke_michel β (7,125 followers Β· π12 π3 π¬1)
> $CYTK "Among patients with symptomatic nonobstructive HCM, treatment with aficamten resulted in a significantly greater change in exercise capacity and patient-reported health status than placebo at 36 weeks." Primary endpoints below. https://t.co/nmcVX6NeV9 $BMY $MYOK https:/...
13. π΄ bearish @yaireinhorn β (19,736 followers Β· π11 π5 π¬0)
> This excellent Citeline chart emphasises another interesting aspect of the $AZN - $BMY merger deal π§΅πand might provide another possible explanation as to why it didnβt happen eventually. This chart looks at the growth, or decline, in the top 10 big Pharma companiesβ pipeline s...
14. βͺ neutral @HOThomasWPhelps β (2,937 followers Β· π18 π0 π¬0)
> $AZN Discontinuing eVOLVE-Lung02 Phase III Reasons accumulating for $AZN interest in $BMY https://t.co/U5RtktUteJ Just three weeks ago, AstraZeneca presented #volrustomig as one of its >$5B peak-year-revenue opportunities w/ key Ph 3 readouts in 2027 https://t.co/W9tmEE...
15. βͺ neutral @ALLKAResearch β (1,894 followers Β· π6 π4 π¬1)
> π₯ AstraZeneca vs. Bristol-Myers Squibb: is the $400B merger even a good idea? $BMY $AZN The rumored merger may be cooling, but the investment opportunity is still heating up. I compare AstraZeneca and Bristol-Myers Squibb across: π₯Valuation π₯Drug portfolios & growth prospec...
16. π΄ bearish @PCM_bio β (3,162 followers Β· π10 π0 π¬2)
> 587 days until Opdivo LOE $bmy .. IPF data incoming, potential stock price reaction outcomes getting more binary everyday they do nothing to address the former (and other LOEs)
17. π’ bullish @BentheFidler (8,509 followers Β· π8 π2 π¬1)
> Bristol Myers wins βmilestoneβ FDA approval of myeloma drug acquired from Celgene https://t.co/STaiSFWrp1 @ByJonGardner $BMY
18. βͺ neutral @bioinvestor24 β (6,513 followers Β· π8 π0 π¬2)
> That is interesting. How r u sure $NVS not going after $SYRE. ? They could go heavy on several immunology areas with SYRE. They definitely need a serious acquisition and unlike nonsense deals over past 2 years. In cardiology too. They could become like $BMY in a...
19. βͺ neutral @Quantumup1 β (4,295 followers Β· π10 π1 π¬0)
> JPMorganπ $NUVB Overweight-$13 $BMY NUVL - $GSK RHHBY PFE RIGL OTSKY JPMorgan said in its initiation report: Our positive thesis centers on 1) early commercial execution for IBTROZI (taletrectinib) in advanced ROS1+ non-small cell lung cancer (NSCLC), where the launch is show...
20. π’ bullish @TheMightyForego (1,105 followers Β· π11 π0 π¬0)
> $BMYRT β Excellent news. Trial as early as November 8, 2027, & $BMY passed on rehearing. Another delay avenue closed. IMO, forget the 2028 dates. W/the appellate detour ending & a trial clock now coming into focus, I remain confident this gets mediated & settled i...